Strengthens the depressing effect on the central nervous system of funds for general anesthesia, hypnotics, sedatives, narcotic analgesics and tranquilizers.
Metabolite procaine (paraaminobenzoic acid) is a sulfonamide antagonist.
Anticoagulants (ardeparin, dalteparin, danaparoid, enoxaparin, heparin, warfarin) increase the risk of bleeding.
When treating the injection site of a local anesthetic with disinfectant solutions containing heavy metals, the risk of developing a local reaction in the form of pain and swelling increases.
Use with MAO inhibitors (furazolidone, procarbazine, selegiline) increases the risk of developing hypotension.
Strengthen and prolong the action of muscle relaxants.
In the appointment of procaine, together with narcotic analgesics, an additive effect is noted that is used in spinal and epidural anesthesia, and respiratory depression is increased.
Vasoconstrictors (epinephrine, methoxamine, phenylephrine) extend the local anesthetic effect.
Procaine reduces the anti-myasthenic effects of drugs, especially when used in high doses,which requires an additional correction of the treatment of myasthenia gravis.
Cholinesterase inhibitors (antimiasthenic drugs, cyclophosphamide, demecarine, ecothiophate, thiotepa) reduce the metabolism of procaine.